| Dr James V Puleo Ii, | |
|
1375 Washington Ave, Suite 101, Albany, NY 12206-1040 | |
| (518) 438-4483 | |
| (518) 482-4201 |
| Full Name | Dr James V Puleo Ii |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 1375 Washington Ave, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487636254 | NPI | - | NPPES |
| 01701275 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ellis Hospital | Schenectady, NY | Hospital |
| St Peter's Hospital | Albany, NY | Hospital |
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Medical College | 1759293111 | 910 |
| Ellis Hospital | 5890607410 | 222 |
News Archive
One-year follow-up results from a pediatric feasibility study of Xeltis bioabsorbable cardiovascular pulmonary graft have been presented as late-breaker at the 96th American Association for Thoracic Surgery annual meeting today.
"Mr. President, you can count us in. With our community, foundation, and corporate partners the Alliance is proud to be a part of Educate to Innovate," said Adolph P. Falcon, Senior Vice President of the National Alliance for Hispanic Health, after attending a White House meeting today where President Obama announced the commitment of companies and nonprofit groups nationwide to encourage students in the STEM fields.
Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells- known as the PI3 kinase (PI3K) pathway-but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
› Verified 3 days ago
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
One-year follow-up results from a pediatric feasibility study of Xeltis bioabsorbable cardiovascular pulmonary graft have been presented as late-breaker at the 96th American Association for Thoracic Surgery annual meeting today.
"Mr. President, you can count us in. With our community, foundation, and corporate partners the Alliance is proud to be a part of Educate to Innovate," said Adolph P. Falcon, Senior Vice President of the National Alliance for Hispanic Health, after attending a White House meeting today where President Obama announced the commitment of companies and nonprofit groups nationwide to encourage students in the STEM fields.
Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells- known as the PI3 kinase (PI3K) pathway-but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
› Verified 3 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
One-year follow-up results from a pediatric feasibility study of Xeltis bioabsorbable cardiovascular pulmonary graft have been presented as late-breaker at the 96th American Association for Thoracic Surgery annual meeting today.
"Mr. President, you can count us in. With our community, foundation, and corporate partners the Alliance is proud to be a part of Educate to Innovate," said Adolph P. Falcon, Senior Vice President of the National Alliance for Hispanic Health, after attending a White House meeting today where President Obama announced the commitment of companies and nonprofit groups nationwide to encourage students in the STEM fields.
Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells- known as the PI3 kinase (PI3K) pathway-but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
› Verified 3 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
One-year follow-up results from a pediatric feasibility study of Xeltis bioabsorbable cardiovascular pulmonary graft have been presented as late-breaker at the 96th American Association for Thoracic Surgery annual meeting today.
"Mr. President, you can count us in. With our community, foundation, and corporate partners the Alliance is proud to be a part of Educate to Innovate," said Adolph P. Falcon, Senior Vice President of the National Alliance for Hispanic Health, after attending a White House meeting today where President Obama announced the commitment of companies and nonprofit groups nationwide to encourage students in the STEM fields.
Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells- known as the PI3 kinase (PI3K) pathway-but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James V Puleo Ii, 1375 Washington Ave, Suite 101, Albany, NY 12206-1040 Ph: (518) 438-4483 | Dr James V Puleo Ii, 1375 Washington Ave, Suite 101, Albany, NY 12206-1040 Ph: (518) 438-4483 |
News Archive
One-year follow-up results from a pediatric feasibility study of Xeltis bioabsorbable cardiovascular pulmonary graft have been presented as late-breaker at the 96th American Association for Thoracic Surgery annual meeting today.
"Mr. President, you can count us in. With our community, foundation, and corporate partners the Alliance is proud to be a part of Educate to Innovate," said Adolph P. Falcon, Senior Vice President of the National Alliance for Hispanic Health, after attending a White House meeting today where President Obama announced the commitment of companies and nonprofit groups nationwide to encourage students in the STEM fields.
Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells- known as the PI3 kinase (PI3K) pathway-but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
› Verified 3 days ago
Arunima Rajbhandary, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 | |
Dr. Rahul Ravilla, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 43 New Scotland Ave Ste 7, Albany, NY 12208 Phone: 518-262-6696 Fax: 518-262-2624 | |
Emmanuelle Cordero Torres, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave Dept Of Nephrology, Albany Medical Center, Albany, NY 12208 Phone: 518-262-5377 | |
Nancy Shrestha, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 5 Palisades Dr Ste 200, Albany, NY 12205 Phone: 518-471-3636 Fax: 518-471-3668 | |
Stephen Hillinger, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 400 Patroon Creek Blvd, Suite 1, Albany, NY 12206 Phone: 518-489-0044 Fax: 518-489-3591 | |
Louis H Gold, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5 Palisades Dr, Ste100, Albany, NY 12205 Phone: 518-438-4496 | |
Sean Joseph Sheehan, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave, Suite 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 |